BIO 2017
How CROs and foundations are partnering to advance drug discovery and development
Disease-focussed foundations and contract research organizations (CROs) are working together to bridge the gap between drug discovery and development.
BIO 2017
Disease-focussed foundations and contract research organizations (CROs) are working together to bridge the gap between drug discovery and development.
The EMA says aligning antibiotic trial requirements with the US FDA and Japan’s PMDA should allow drug firms to conduct single global development programmes.
DIA 2017
Parexel has introduced a new ecosystem of integrated data-driven services as the industry looks to gain better insights from myriad information sources.
Anhui Sunhere Pharmaceutical Excipients has been granted a Chinese patent for an enzyme-based method of making starch soluble.
Takeda has completed a €100m ($112m) oral solid dosage production facility in Germany.
Parexel International Corporation has signed a definite agreement to be acquired by the private equity firm Pamplona Capital Management, LLP.